1. Home
  2. finance
  3. news
  4. Meet the rising stars of Wall Street who are navigating volatile markets and transforming the industry while still in their 20s and 30s

Meet the rising stars of Wall Street who are navigating volatile markets and transforming the industry while still in their 20s and 30s

Matt Turner,Spriha Srivastava,Jordan Parker Erb,Lisa Ryan   

Meet the rising stars of Wall Street who are navigating volatile markets and transforming the industry while still in their 20s and 30s

Hi, I'm Matt Turner, the editor in chief of business at Insider. Welcome back to Insider Weekly, a roundup of some of our top stories.

On the agenda today:

But first, we have a dispatch from Singapore. Our London bureau chief and international executive editor Spriha Srivastava has been there for the past week attending one of the major conferences in the region. Without further ado, let's hear from Spriha…

If this was forwarded to you, sign up here. Download Insider's app here.

Dispatch from Milken Asia Summit

I was in Singapore this week as the country geared up for its first Grand Prix Formula One since the pandemic. There was so much excitement in the air, London bureau chief and international executive editor Spriha Srivastava writes.

Singapore also hosted a number of conferences this week. I was at the Milken Asia Summit, where I moderated two panels (you can watch them here). I also got a chance to meet and hear from key business leaders from around the world.

  • My panel focused on how technology and the need for innovation has pushed entrepreneurs into the startup ecosystem. But all of this in the background of an adverse economic climate — how sustainable is it?
  • Concerns around current economic conditions made their way into a lot of conversations — business leaders like the ex-Mastercard CEO Ajay Banga and PIMCO's John Studzinski spoke about recession, inflation, and the current crisis in the UK economy.
  • They say the fintech sun rises in the East, and that was evident at the conference. I met a number of startup CEOs, and the key theme was how to create a "built-to-last" company. How do you build a sustainable tech company that evolves in a fast-paced, ever-changing tech world?
  • The conference wasn't limited to business and tech leaders. I unexpectedly bumped into Henry Golding, the Malaysian-British actor known for his role in "Crazy Rich Asians." Golding took part in a panel on Asia and Hollywood, along with "Sima aunty" from Netflix's "Indian Matchmaking."

Now, on to this week's stories.

Introducing the rising stars of Wall Street

As Wall Street navigates volatile markets, fewer deals, and plummeting company valuations, Insider pinpointed the players on the rise despite the challenges — grabbing opportunities as they see them.

We narrowed down the young professionals on the runway to success, even as banks and money managers brace for cutbacks. In conversations with these rising stars — including leaders from firms like JPMorgan, Blackstone, and Citadel Securities — they reflected on their successes, challenges, and best career advice.

Meet the 25 up-and-comers shaping the industry.

Your real-estate agent is not your friend

Homebuyers aren't required to use a real-estate agent, but few buyers have the time or expertise to navigate the housing market on their own. And even though agents are the friendly face of a bewildering system, they can drive up the cost of homes by pushing for moves that will drive up their commissions.

As a result, Americans pay as much as $72 billion more a year for real-estate agents compared to homebuyers in other developed nations, robbing them of a significant portion of what is often the biggest investment of their lives.

Here's how to avoid real estate's most common rip-offs.

Also read:

Breakthrough positive result in Alzheimer's trial

Alzheimer's disease affects roughly 6.5 million Americans — and there is no cure. But a consequential new study around a new treatment may transform how pharmaceutical companies and doctors treat the disease.

The long-awaited results come from the companies Biogen and Eisai. The companies found their medication, called lecanemab, slowed the rate of cognitive decline by 27% in a trial of patients in the early stages of the disease.

Here's how this may transform Alzheimer's treatment.

The golden era of Big Tech moonshots is over

For years, tech giants have allocated time and resources into pursuing radical, potentially world-changing projects (think self-driving cars, drones, or balloons that beam high-speed internet).

But recently, amid a gloomy economic climate, tech titans like Amazon, Google, Microsoft, and Facebook have begun pulling back on these kinds of experimental projects and "moonshot" ideas — or assigning them to the graveyard entirely.

Why Big Tech is going back to the basics.

This week's quote:

"You have to use the debt as a motivating factor. Looking at that debt and knowing that it was preventing me from starting my business and moving on with the life I wanted made me want to repay it faster."

More of this week's top reads:

Plus: Stay up to date with the latest business news throughout your weekdays by checking out The Refresh from Insider, a dynamic audio news brief from the Insider newsroom. Listen here tomorrow.

Curated by Matt Turner. Edited by Jordan Parker Erb and Lisa Ryan. Sign up for more Insider newsletters here.